Lymphedema Management Physiotherapy Oakville | RCP Health
Lymphedema is a chronic condition involving the abnormal accumulation of protein-rich fluid in the soft tissues, resulting from damage or dysfunction within the lymphatic system. Unlike ordinary swelling that resolves with rest and elevation, lymphedema reflects a structural problem — the lymphatic vessels simply cannot drain fluid at the rate it is being produced. The result is persistent, sometimes progressive swelling, most commonly in a limb, that affects not only physical comfort but daily function, skin integrity, and quality of life. For many patients, understanding what is actually happening beneath the skin is the first step toward managing this condition effectively.
Primary vs Secondary Lymphedema: Understanding the Difference
Lymphedema is broadly categorized as either primary or secondary. Primary lymphedema arises from a congenital abnormality in lymphatic vessel development — meaning the lymphatic system was never fully formed or functional from birth. It may present at birth, during puberty, or in early adulthood, and while it is less common, it is no less challenging to manage. Secondary lymphedema, by contrast, develops as a result of damage to a previously healthy lymphatic system. This is the far more common presentation in clinical practice, and it is most frequently associated with cancer treatment.
In clinical practice, I frequently see patients who arrive several months — sometimes years — after completing cancer treatment with swelling they assumed would eventually resolve on its own. What surprises many of these patients is learning that lymphedema is not simply a side effect that fades with time, but a condition that typically requires active, structured management. The earlier that management begins, the more effectively progression can be slowed.
Why Cancer Treatment Affects the Lymphatic System
The connection between cancer treatment and lymphedema is primarily surgical and radiological. When lymph nodes are removed during cancer surgery — as is standard in many breast, gynaecological, melanoma, and head and neck cancer treatments — the lymphatic drainage pathway is disrupted. Radiation therapy compounds this by causing fibrotic changes in lymphatic tissue, further reducing the capacity of the remaining vessels to transport fluid. Breast cancer-related lymphedema, affecting the arm and sometimes the hand, chest wall, or breast itself, is among the most commonly referred presentations I assess at RCP Health Oakville.
A nuanced clinical insight that many patients are not told early enough: the risk of lymphedema is not uniform across all patients who undergo lymph node dissection. The extent of nodal removal, the specific radiation field, body mass index, and even post-operative infection history all influence individual risk. A patient who had two nodes removed carries a meaningfully different risk profile than one who had an axillary clearance of twenty nodes. This is why baseline limb volume measurements taken before cancer treatment — something called pre-operative surveillance — can be enormously useful when available, allowing us to identify early-stage swelling before it becomes clinically visible.
Facts and Figures
According to the World Health Organization, lymphatic filariasis — a parasitic cause of secondary lymphedema — affects over 120 million people globally, making it one of the leading infectious causes of disability worldwide. In high-income countries such as Canada, cancer-related lymphedema is the predominant cause. Research published in the Journal of Clinical Oncology has reported that breast cancer-related lymphedema affects approximately 20% of patients following axillary lymph node dissection, with rates varying based on treatment extent and post-operative complications.
Complete Decongestive Therapy at RCP Health Oakville
The gold standard treatment for lymphedema is Complete Decongestive Therapy, or CDT — an evidence-based, multi-component approach that physiotherapists with specialized training are qualified to provide. At RCP Health Oakville, CDT is delivered across two phases: an intensive treatment phase aimed at reducing limb volume, and a maintenance phase designed to preserve those gains and prevent recurrence.
CDT includes four core components:
- Manual Lymphatic Drainage (MLD): A specialized, light-pressure massage technique that stimulates superficial lymphatic vessels and redirects fluid toward functioning lymphatic pathways. This is distinctly different from deep tissue massage and requires specific training in lymphatic anatomy.
- Compression Therapy: Applied through multilayer bandaging during the intensive phase, then transitioning to custom-fitted compression garments for daily maintenance. Garment selection — including pressure class, fabric type, and style — is guided by the individual’s limb shape, skin condition, and activity level.
- Therapeutic Exercise: Specific limb movements performed while wearing compression support the lymphatic pump effect, using muscle contractions to move fluid proximally. Exercise programs are graded and individualized, not generic.
- Skin and Wound Care: Lymphedematous tissue is vulnerable to infection, particularly cellulitis. Education around skin hygiene, moisturising, and early recognition of infection signs is a non-negotiable part of any management plan.
- Patient Education: Understanding activity precautions, limb positioning, travel considerations, and when to seek medical review gives patients meaningful control over their condition long-term.
A pattern I notice consistently in patients who do well with lymphedema management is the shift from feeling reactive — always chasing flare-ups — to feeling proactive. When patients understand their triggers, maintain their compression routines, and keep up with home exercise, the fluctuations become less dramatic and more manageable. Presentations that respond particularly well to CDT are those caught early, with pitting edema and intact skin. When fibrotic tissue changes are already established, or when there is significant dermal thickening, management becomes more complex, progress is slower, and close collaboration with the referring oncologist or lymphedema physician becomes more important.
Lymphedema is a lifelong condition, but it is not an unmanageable one. With the right clinical guidance, structured therapy, and patient engagement, most people living with lymphedema can maintain good function and meaningful quality of life. If you or someone you care for has been diagnosed with lymphedema — or is at risk following cancer treatment — early assessment makes a genuine difference.